Giardiasis Medication: Antibiotics (2024)

  1. Nakao JH, Collier SA, Gargano JW. Giardiasis and subsequent irritable bowel syndrome: a longitudinal cohort study using health insurance data. J Infect Dis. 2017 Mar 1. 215(5):798-805. [QxMD MEDLINE Link].

  2. Beer KD, Collier SA, Du F, Gargano JW. Giardiasis diagnosis and treatment practices among commercially insured persons in the United States. Clin Infect Dis. 2017 May 1. 64(9):1244-50. [QxMD MEDLINE Link].

  3. Daly ER, Roy SJ, Blaney DD, et al. Outbreak of giardiasis associated with a community drinking-water source. Epidemiol Infect. 2010 Apr. 138(4):491-500. [QxMD MEDLINE Link].

  4. Robertson L, Gjerde B, Hansen EF, Stachurska-Hagen T. A water contamination incident in Oslo, Norway during October 2007; a basis for discussion of boil-water notices and the potential for post-treatment contamination of drinking water supplies. J Water Health. 2009 Mar. 7(1):55-66. [QxMD MEDLINE Link].

  5. Eisenstein L, Bodager D, Ginzl D. Outbreak of giardiasis and cryptosporidiosis associated with a neighborhood interactive water fountain--Florida, 2006. J Environ Health. 2008 Oct. 71(3):18-22; quiz 49-50. [QxMD MEDLINE Link].

  6. Nishi L, Baesso ML, Santana RG, Fregadolli P, Falavigna DL, Falavigna-Guilherme AL. Investigation of Cryptosporidium spp. and Giardia spp. in a public water-treatment system. Zoonoses Public Health. 2009 Jun. 56(5):221-8. [QxMD MEDLINE Link].

  7. Escobedo AA, Almirall P, Gonzalez-Fraile E, Ballesteros J. Efficacy of mebendazole in paediatric patients with giardiasis: a systematic review and meta-analysis. Acta Trop. 2018 Aug 6. 188:50-7. [QxMD MEDLINE Link].

  8. Hill DR. Giardia lamblia. Mandell GL, Bennett JE, Dolin R. Principles and Practice of Infectious Diseases. 2. 6th ed. Philadelphia, Pennsylvania: Churchill Livingstone An Imprint of Elsevier Inc.; 2005. 277: 3198-3203.

  9. Huston CD. Intestinal protozoa. Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 8th ed. Philadelphia, PA: Saunders; 2006. Vol 2: 2420-3.

  10. Robertson LJ, Forberg T, Gjerde BK. Giardia cysts in sewage influent in Bergen, Norway 15-23 months after an extensive waterborne outbreak of giardiasis. J Appl Microbiol. 2008 Apr. 104(4):1147-52. [QxMD MEDLINE Link].

  11. Ryu H, Alum A, Mena KD, Abbaszadegan M. Assessment of the risk of infection by Cryptosporidium and Giardia in non-potable reclaimed water. Water Sci Technol. 2007. 55(1-2):283-90. [QxMD MEDLINE Link].

  12. Farthing MJ. Giardiasis. Gastroenterol Clin North Am. 1996 Sep. 25(3):493-515. [QxMD MEDLINE Link].

  13. Sears CL. Giardiasis. Giardiasis. Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, PA: Saunders; 2007. 2402-4.

  14. Monis PT, Thompson RC. Cryptosporidium and Giardia-zoonoses: fact or fiction?. Infect Genet Evol. 2003 Nov. 3(4):233-44. [QxMD MEDLINE Link].

  15. Huang DB, White AC. An updated review on Cryptosporidium and Giardia. Gastroenterol Clin North Am. 2006 Jun. 35(2):291-314, viii. [QxMD MEDLINE Link].

  16. Thompson RC, Palmer CS, O'Handley R. The public health and clinical significance of Giardia and Cryptosporidium in domestic animals. Vet J. 2008 Jul. 177(1):18-25. [QxMD MEDLINE Link].

  17. Ballweber LR, Xiao L, Bowman DD, Kahn G, Cama VA. Giardiasis in dogs and cats: update on epidemiology and public health significance. Trends Parasitol. 2010 Apr. 26(4):180-9. [QxMD MEDLINE Link].

  18. John CC. Giardiasis and balantidiasis. Kliegman RM, Behrman BE, Jenson HB, Stanton BF, eds. Nelson Textbook of Pediatrics. 18th ed. Philadelphia, PA: Saunders; 2007. 1462-4.

  19. Leung AKC, Leung AAM, Wong AHC, Sergi CM, Kam JKM. Giardiasis: an overview. Recent Pat Inflamm Allergy Drug Discov. 2019. 13(2):134-43. [QxMD MEDLINE Link]. [Full Text].

  20. Adam RD. Biology of Giardia lamblia. Clin Microbiol Rev. 2001 Jul. 14(3):447-75. [QxMD MEDLINE Link]. [Full Text].

  21. Dixon BR. Giardia duodenalis in humans and animals - transmission and disease. Res Vet Sci. 2021 Mar. 135:283-9. [QxMD MEDLINE Link].

  22. Waldram A, Vivancos R, Hartley C, Lamden K. Prevalence of Giardia infection in households of Giardia cases and risk factors for household transmission. BMC Infect Dis. 2017 Jul 11. 17(1):486. [QxMD MEDLINE Link]. [Full Text].

  23. Lopez CE, Dykes AC, Juranek DD, et al. Waterborne giardiasis: a communitywide outbreak of disease and a high rate of asymptomatic infection. Am J Epidemiol. 1980 Oct. 112(4):495-507. [QxMD MEDLINE Link].

  24. Buret AG. Mechanisms of epithelial dysfunction in giardiasis. Gut. 2007 Mar. 56(3):316-7. [QxMD MEDLINE Link]. [Full Text].

  25. Hill DR. Giardiasis. Issues in diagnosis and management. Infect Dis Clin North Am. 1993 Sep. 7(3):503-25. [QxMD MEDLINE Link].

  26. Hanevik K, Hausken T, Morken MH, et al. Persisting symptoms and duodenal inflammation related to Giardia duodenalis infection. J Infect. 2007 Dec. 55(6):524-30. [QxMD MEDLINE Link].

  27. Buret AG. Pathophysiology of enteric infections with Giardia duodenalius. Parasite. 2008 Sep. 15(3):261-5. [QxMD MEDLINE Link].

  28. Faubert G. Immune response to Giardia duodenalis. Clin Microbiol Rev. 2000 Jan. 13(1):35-54. [QxMD MEDLINE Link]. [Full Text].

  29. Liu J, Ma'ayeh S, Peirasmaki D, Lundstrom-Stadelmann B, Hellman L, Svard SG. Secreted Giardia intestinalis cysteine proteases disrupt intestinal epithelial cell junctional complexes and degrade chemokines. Virulence. 2018 Dec 31. 9 (1):879-94. [QxMD MEDLINE Link].

  30. Buret AG. Immunopathology of giardiasis: the role of lymphocytes in intestinal epithelial injury and malfunction. Mem Inst Oswaldo Cruz. 2005 Mar. 100 Suppl 1:185-90. [QxMD MEDLINE Link].

  31. Garcia LS. Intestinal Protozoa: Flagellates and Ciliates. Diagnostic Medical Parasitology. 5th ed. Washington, D.C: ASM Press; 2007. 3: 36-49.

  32. Roxstrom-Lindquist K, Palm D, Reiner D, Ringqvist E, Svard SG. Giardia immunity--an update. Trends Parasitol. 2006 Jan. 22(1):26-31. [QxMD MEDLINE Link].

  33. Panaro MA, Cianciulli A, Mitolo V, et al. Caspase-dependent apoptosis of the HCT-8 epithelial cell line induced by the parasite Giardia intestinalis. FEMS Immunol Med Microbiol. 2007 Nov. 51(2):302-9. [QxMD MEDLINE Link].

  34. Liu C, Crawford JM. The gastrointestinal tract. Kumar V, Abbas AK, Fausto N, eds. Robbins and Cotran: Pathologic Basis of Disease. 7th ed. Philadelphia: Saunders; 2004. 840. [Full Text].

  35. Sprong H, Caccio SM, van der Giessen JW, ZOOPNET network and partners. Identification of zoonotic genotypes of Giardia duodenalis. PLoS Negl Trop Dis. 2009 Dec 1. 3(12):e558. [QxMD MEDLINE Link]. [Full Text].

  36. Lebbad M, Petersson I, Karlsson L, et al. Multilocus genotyping of human Giardia isolates suggests limited zoonotic transmission and association between assemblage B and flatulence in children. PLoS Negl Trop Dis. 2011 Aug. 5(8):e1262. [QxMD MEDLINE Link]. [Full Text].

  37. Caccio SM, Ryan U. Molecular epidemiology of giardiasis. Mol Biochem Parasitol. 2008 Aug. 160(2):75-80. [QxMD MEDLINE Link].

  38. Minvielle MC, Molina NB, Polverino D, Basualdo JA. First genotyping of Giardia lamblia from human and animal feces in Argentina, South America. Mem Inst Oswaldo Cruz. 2008 Feb. 103(1):98-103. [QxMD MEDLINE Link].

  39. Robertson LJ, Forberg T, Hermansen L, Gjerde BK, Langeland N. Molecular characterisation of Giardia isolates from clinical infections following a waterborne outbreak. J Infect. 2007 Jul. 55(1):79-88. [QxMD MEDLINE Link].

  40. Abdul-Wahid A, Faubert G. Characterization of the local immune response to cyst antigens during the acute and elimination phases of primary murine giardiasis. Int J Parasitol. 2008 May. 38(6):691-703. [QxMD MEDLINE Link].

  41. Rendtorff RC. The experimental transmission of human intestinal protozoan parasites. II. Giardia lamblia cysts given in capsules. Am J Hyg. 1954 Mar. 59(2):209-20. [QxMD MEDLINE Link].

  42. Adam EA, Yoder JS, Gould LH, Hlavsa MC, Gargano JW. Giardiasis outbreaks in the United States, 1971-2011. Epidemiol Infect. 2016 Oct. 144(13):2790-801. [QxMD MEDLINE Link]. [Full Text].

  43. Conners EE, Miller AD, Balachandran N, Robinson BM, Benedict KM. Giardiasis outbreaks - United States, 2012-2017. MMWR Morb Mortal Wkly Rep. 2021 Mar 5. 70(9):304-7. [QxMD MEDLINE Link]. [Full Text].

  44. Dawson D. Foodborne protozoan parasites. Int J Food Microbiol. 2005 Aug 25. 103(2):207-27. [QxMD MEDLINE Link].

  45. Fort GG, Mikolich DJ, Policar M. Giardiasis. Ferri FF, ed. Ferri's Clinical Advisor. Philadelphia, PA: Mosby; 2009. 358.

  46. Yoder JS, Beach MJ. Giardiasis surveillance--United States, 2003-2005. MMWR Surveill Summ. 2007 Sep 7. 56(7):11-8. [QxMD MEDLINE Link].

  47. Pickering LK, Woodward WE, DuPont HL, Sullivan P. Occurrence of Giardia lamblia in children in day care centers. J Pediatr. 1984 Apr. 104(4):522-6. [QxMD MEDLINE Link].

  48. Pickering LK. Giardia lamblia (Giardiasis). Long SS, Pickering LK, Prober CG, eds. Principles and Practice of Pediatric Infectious Diseases. 3rd ed. Philadelphia, PA: Churchill Livingstone; 2008. 1241-5.

  49. Caccio SM, Thompson RC, McLauchlin J, Smith HV. Unravelling Cryptosporidium and Giardia epidemiology. Trends Parasitol. 2005 Sep. 21(9):430-7. [QxMD MEDLINE Link].

  50. Hajare ST, Chekol Y, Chauhan NM. Assessment of prevalence of Giardia lamblia infection and its associated factors among government elementary school children from Sidama zone, SNNPR, Ethiopia. PLoS One. 2022. 17(3):e0264812. [QxMD MEDLINE Link]. [Full Text].

  51. Giangaspero A, Berrilli F, Brandonisio O. Giardia and Cryptosporidium and public health: the epidemiological scenario from the Italian perspective. Parasitol Res. 2007 Oct. 101(5):1169-82. [QxMD MEDLINE Link].

  52. Laupland KB, Church DL. Population-based laboratory surveillance for Giardia sp. and Cryptosporidium sp. infections in a large Canadian health region. BMC Infect Dis. 2005 Sep 16. 5:72. [QxMD MEDLINE Link]. [Full Text].

  53. Hoque ME. Giardiasis. Rakel RE, Bope ET, eds. Conn's Current Therapy. Philadelphia, PA: Saunders; 2008. 67/15.

  54. Brodsky RE, Spencer HC Jr, Schultz MG. Giardiasis in American travelers to the Soviet Union. J Infect Dis. 1974 Sep. 130(3):319-23. [QxMD MEDLINE Link].

  55. Dib HH, Lu SQ, Wen SF. Prevalence of Giardia lamblia with or without diarrhea in South East, South East Asia and the Far East. Parasitol Res. 2008 Jul. 103(2):239-51. [QxMD MEDLINE Link].

  56. Gelanew T, Lalle M, Hailu A, Pozio E, Caccio SM. Molecular characterization of human isolates of Giardia duodenalis from Ethiopia. Acta Trop. 2007 May. 102(2):92-9. [QxMD MEDLINE Link].

  57. Quihui L, Morales GG, Mendez RO, Leyva JG, Esparza J, Valencia ME. Could giardiasis be a risk factor for low zinc status in schoolchildren from northwestern Mexico? A cross-sectional study with longitudinal follow-up. BMC Public Health. 2010 Feb 20. 10(1):85. [QxMD MEDLINE Link]. [Full Text].

  58. Thompson SC. Giardia lamblia in children and the child care setting: a review of the literature. J Paediatr Child Health. 1994 Jun. 30(3):202-9. [QxMD MEDLINE Link].

  59. Escobedo AA, Almirall P, Alfonso M, Cimerman S, Rey S, Terry SL. Treatment of intestinal protozoan infections in children. Arch Dis Child. 2009 Jun. 94(6):478-82. [QxMD MEDLINE Link].

  60. Jimenez JC, Pinon A, Dive D, Capron M, Dei-Cas E, Convit J. Antibody response in children infected with Giardia intestinalis before and after treatment with Secnidazole. Am J Trop Med Hyg. 2009 Jan. 80(1):11-5. [QxMD MEDLINE Link].

  61. Dizdar V, Gilja OH, Hausken T. Increased visceral sensitivity in Giardia-induced postinfectious irritable bowel syndrome and functional dyspepsia. Effect of the 5HT3-antagonist ondansetron. Neurogastroenterol Motil. 2007 Dec. 19(12):977-82. [QxMD MEDLINE Link].

  62. Penrose AS, Wells EV, Aiello AE. Infectious causation of chronic disease: examining the relationship between Giardia lamblia infection and irritable bowel syndrome. World J Gastroenterol. 2007 Sep 14. 13(34):4574-8. [QxMD MEDLINE Link].

  63. Hanevik K, Dizdar V, Langeland N, Hausken T. Development of functional gastrointestinal disorders after Giardia lamblia infection. BMC Gastroenterol. 2009 Apr 21. 9:27. [QxMD MEDLINE Link]. [Full Text].

  64. Hanevik K, Wensaas KA, Rortveit G, et al. Irritable bowel syndrome and chronic fatigue 6 years after Giardia infection: a controlled prospective cohort study. Clin Infect Dis. 2014 Nov 15. 59(10):1394-400. [QxMD MEDLINE Link].

  65. Ouattara M, N'guessan NA, Yapi A, N'goran EK. Prevalence and spatial distribution of Entamoeba histolytica/dispar and Giardia lamblia among schoolchildren in Agboville area (Côte d'Ivoire). PLoS Negl Trop Dis. 2010 Jan 19. 4(1):e574. [QxMD MEDLINE Link]. [Full Text].

  66. Heyworth MF. Diagnostic testing for Giardia infections. Trans R Soc Trop Med Hyg. 2014 Mar. 108(3):123-5. [QxMD MEDLINE Link].

  67. Nagaty IM, Hegazi MM. Dot-ELISA copro-antigen and direct stool examination in diagnosis of giardiasis patients. J Egypt Soc Parasitol. 2007 Aug. 37(2):641-8. [QxMD MEDLINE Link].

  68. Strand EA, Robertson LJ, Hanevik K, Alvsvag JO, Morch K, Langeland N. Sensitivity of a Giardia antigen test in persistent giardiasis following an extensive outbreak. Clin Microbiol Infect. 2008 Nov. 14(11):1069-71. [QxMD MEDLINE Link].

  69. Mayer CL, Palmer CJ. Evaluation of PCR, nested PCR, and fluorescent antibodies for detection of Giardia and Cryptosporidium species in wastewater. Appl Environ Microbiol. 1996 Jun. 62(6):2081-5. [QxMD MEDLINE Link].

  70. Prasertbun R, Sukthana Y, Popruk S. Real-time PCR: benefits for detection of mild and asymptomatic Giardia infections. Trop Med Health. 2012 Jun. 40(2):31-5. [QxMD MEDLINE Link].

  71. Youn S, Kabir M, Haque R, Petri WA Jr. Evaluation of a screening test for detection of giardia and cryptosporidium parasites. J Clin Microbiol. 2009 Feb. 47(2):451-2. [QxMD MEDLINE Link]. [Full Text].

  72. Morken MH, Nysaeter G, Strand EA, Hausken T, Berstad A. Lactulose breath test results in patients with persistent abdominal symptoms following Giardia lamblia infection. Scand J Gastroenterol. 2008. 43(2):141-5. [QxMD MEDLINE Link].

  73. Busatti HG, Santos JF, Gomes MA. The old and new therapeutic approaches to the treatment of giardiasis: where are we?. Biologics. 2009. 3:273-87. [QxMD MEDLINE Link]. [Full Text].

  74. Busatti HG, Vieira AE, Viana JC, et al. Effect of metronidazole analogues on Giardia lamblia cultures. Parasitol Res. 2007 Dec. 102(1):145-9. [QxMD MEDLINE Link].

  75. Monajemzadeh SM, Monajemzadeh M. Comparison of iron and hematological indices in Giardia lamblia infection before and after treatment in 102 children in Ahwaz, Iran. Med Sci Monit. 2008 Jan. 14(1):CR19-23. [QxMD MEDLINE Link].

  76. Gardner TB, Hill DR. Treatment of giardiasis. Clin Microbiol Rev. 2001 Jan. 14(1):114-28. [QxMD MEDLINE Link]. [Full Text].

  77. Petri WA. Treatment of giardiasis. Curr Treat Options Gastroenterol. 2005 Feb. 8(1):13-7. [QxMD MEDLINE Link].

  78. Escobedo AA, Ballesteros J, Gonzalez-Fraile E, Almirall P. A meta-analysis of the efficacy of albendazole compared with tinidazole as treatments for Giardia infections in children. Acta Trop. 2016 Jan. 153:120-7. [QxMD MEDLINE Link].

  79. Bourque DL, Neumayr A, Libman M, Chen LH. Treatment strategies for nitroimidazole-refractory giardiasis: a systematic review. J Travel Med. 2022 Jan 17. 29(1):taab120. [QxMD MEDLINE Link].

  80. [Guideline] Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America Clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017 Nov 29. 65(12):e45-e80. [QxMD MEDLINE Link]. [Full Text].

  81. Ordonez-Mena JM, McCarthy ND, Fanshawe TR. Comparative efficacy of drugs for treating giardiasis: a systematic update of the literature and network meta-analysis of randomized clinical trials. J Antimicrob Chemother. 2018 Mar 1. 73(3):596-606. [QxMD MEDLINE Link]. [Full Text].

  82. Nabarro LE, Lever RA, Armstrong M, Chiodini PL. Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008-2013. Clin Microbiol Infect. 2015 Aug. 21(8):791-6. [QxMD MEDLINE Link].

  83. Carter ER, Nabarro LE, Hedley L, Chiodini PL. Nitroimidazole-refractory giardiasis: a growing problem requiring rational solutions. Clin Microbiol Infect. 2018 Jan. 24(1):37-42. [QxMD MEDLINE Link].

  84. Ydsten KA, Hellgren U, Asgeirsson H. Quinacrine treatment of nitroimidazole-refractory giardiasis. J Infect Dis. 2022 May 16. 225(10):1773-6. [QxMD MEDLINE Link]. [Full Text].

  85. van den Bijllaardt W, Overdevest IT, Buiting AG, Verweij JJ. Rapid clearance of Giardia lamblia DNA from the gut after successful treatment. Clin Microbiol Infect. 2014 Nov. 20(11):O972-4. [QxMD MEDLINE Link].

  86. Kiser JD, Paulson CP, Brown C. Clinical inquiries. What's the most effective treatment for giardiasis?. J Fam Pract. 2008 Apr. 57(4):270-2. [QxMD MEDLINE Link].

  87. Gardner TB, Hill DR. Treatment of giardiasis. Clin Microbiol Rev. 2001 Jan. 14(1):114-28. [QxMD MEDLINE Link].

  88. Wright JM, Dunn LA, Upcroft P, Upcroft JA. Efficacy of antigiardial drugs. Expert Opin Drug Saf. 2003 Nov. 2(6):529-41. [QxMD MEDLINE Link].

  89. Mahmud MA, Chappell CL, Hossain MM, Huang DB, Habib M, DuPont HL. Impact of breast-feeding on Giardia lamblia infections in Bilbeis, Egypt. Am J Trop Med Hyg. 2001 Sep. 65(3):257-60. [QxMD MEDLINE Link].

  90. Escobedo AA, Cimerman S. Giardiasis: a pharmacotherapy review. Expert Opin Pharmacother. 2007 Aug. 8(12):1885-902. [QxMD MEDLINE Link].

  91. Rayan P, Matthews B, McDonnell PA, co*ck IE. Terminalia ferdinandiana extracts as inhibitors of Giardia duodenalis proliferation: a new treatment for giardiasis. Parasitol Res. 2015 Jul. 114(7):2611-20. [QxMD MEDLINE Link].

  92. Lopez-Romero G, Quintero J, Astiazaran-Garcia H, Velazquez C. Host defences against Giardia lamblia. Parasite Immunol. 2015 Aug. 37(8):394-406. [QxMD MEDLINE Link].

  93. Astiazaran-Garcia H, Inigo-Figueroa G, Quihui-Cota L, Anduro-Corona I. Crosstalk between zinc status and Giardia infection: a new approach. Nutrients. 2015 Jun 3. 7(6):4438-52. [QxMD MEDLINE Link].

  94. Krumrie S, Capewell P, Smith-Palmer A, Mellor D, Weir W, Alexander CL. A scoping review of risk factors and transmission routes associated with human giardiasis outbreaks in high-income settings. Curr Res Parasitol Vector Borne Dis. 2022 Feb 21. 2:100084. [QxMD MEDLINE Link]. [Full Text].

Giardiasis Medication: Antibiotics (2024)

FAQs

Giardiasis Medication: Antibiotics? ›

Metronidazole is the antimicrobial agent most commonly used in the treatment of giardiasis in the United States (250 mg three times daily for 5-7 days). It has a cure rate of up to 85-90%, although resistance is becoming more prevalent.

What is the best antibiotic for Giardia? ›

When signs and symptoms are severe or the infection persists, doctors usually treat giardia infection with medications such as: Metronidazole (Flagyl). Metronidazole is the most commonly used antibiotic for giardia infection. Side effects may include nausea and a metallic taste in the mouth.

What are the 4 pills for Giardia? ›

Antibiotics for giardiasis include:
  • Metronidazole (Flagyl®).
  • Tinidazole (Tindamax®).
  • Nitazoxanide (Alinia®).
  • Paromomycin (Humatin®).

Does Giardia go away with antibiotics? ›

Treatment for Giardia involves taking an antibiotic. Depending on the antibiotic given, treatment may be needed for only one day or for several days. In most cases, this is enough to eliminate the infection and its symptoms.

What emergency medicine treats Giardia? ›

Metronidazole is the standard treatment, although alternative medications like tinidazole, nitazoxanide, mebendazole, albendazole, and paromomycin can be used.

What naturally kills Giardia? ›

Thankfully giardia is quite susceptible to many of our herbal antimicrobials including garlic (11), oregano, and guava leaf (12). Many other herbal antimicrobials are helpful, and in most cases natural treatment for Giardia can be effective in as little as two weeks of herbal treatment.

What is the 5 day treatment for Giardia? ›

Standard treatment for giardiasis consists of antibiotic therapy. Metronidazole (often 250 mg three times daily in adults for 5-7 days) is the most commonly prescribed antibiotic for this condition.

What probiotic kills Giardia? ›

Experimental studies have demonstrated that Giardia infection reduced both the severity and duration when probiotics (Lactobacillus rhamnosus, Lactobacillus casei) were administered prior or simultaneous to the parasite.

Why is Giardia so hard to treat? ›

Thus, drug resistance in Giardia is the ability of this parasite to survive in the presence of an antimicrobial drug dose that would normally kill it or limit its growth.

What supplement kills Giardia? ›

Berberine is a compound found in several plants that has been shown to be effective against several pathogens that cause diarrhea, including Giardia.

Can your body clear Giardia on its own? ›

Mild infections of giardiasis parasites may clear up on their own in a few weeks. However, more severe cases of giardia may cause long-term symptoms and complications.

What foods not to eat with Giardia? ›

Eat slowly and avoid foods that are hard to digest or may irritate your stomach, such as foods with acid (like tomatoes or oranges), spicy or fatty food, meats, and raw vegetables. You may be able to go back to your normal diet in a few days.

What color is Giardia stool? ›

Clinical signs.

The diarrhea is a result of intestinal malabsorption and is often characterized as voluminous, light-colored, foul-smelling, and soft to watery. Weight loss has also been associated with clinical infection.

Should I go to urgent care if I think I have Giardia? ›

When to Seek Medical Care for Giardiasis. Contact a doctor for appropriate diagnosis and treatment if your symptoms are consistent with giardiasis, if symptoms last despite treatment, or if any new symptoms develop. People should not automatically go to the hospital for these conditions.

What drug kills Giardia? ›

Metronidazole is the antimicrobial agent most commonly used in the treatment of giardiasis in the United States (250 mg three times daily for 5-7 days). It has a cure rate of up to 85-90%, although resistance is becoming more prevalent.

What OTC medicine is good for giardiasis? ›

What is the treatment for giardiasis? Metronidazole (Flagyl) is the primary drug of choice. However, there are several other prescription medications that are effective. Over–the-counter medications, such as Pepto-Bismol or Kaopectate, should only be used after the evaluation and recommendation of a physician.

What is the new treatment for Giardia? ›

Ayradia is the first FDA-approved animal drug for treating Giardia duodenalis infections. Ayradia is available by prescription from a licensed veterinarian and administered orally at 25 mg/kg (11.3 mg/lb) of body weight, using the supplied syringe, twice daily for five consecutive days.

What do vets prescribe for Giardia? ›

Medication. Fenbendazole is a common deworming medication used to treat Giardia. Another treatment option is an antibiotic called metronidazole. Your veterinarian may also use the two medications in combination.

Why is Giardia hard to get rid of? ›

Thus, drug resistance in Giardia is the ability of this parasite to survive in the presence of an antimicrobial drug dose that would normally kill it or limit its growth.

What is the OTC treatment for Giardia? ›

If you have giardiasis, be sure to drink plenty of fluids to prevent dehydration. Over-the-counter medications for diarrhea, such as loperamide (Imodium), may help your symptoms. Wash your hands frequently if you have giardiasis or if you are caring for a person or animal with this infection.

Top Articles
How to Measure and Reduce Donor Churn
The FHA Loan Process: Step by Step | Latest News, Tips and Trends about Mortgage BPO USA
Craigslist Cars And Trucks For Sale By Owner Indianapolis
New Slayer Boss - The Araxyte
Co Parts Mn
Hallowed Sepulchre Instances & More
Lesson 2 Homework 4.1
Sport Clip Hours
charleston cars & trucks - by owner - craigslist
Cvb Location Code Lookup
Union Ironworkers Job Hotline
The best TV and film to watch this week - A Very Royal Scandal to Tulsa King
Lowe's Garden Fence Roll
The best firm mattress 2024, approved by sleep experts
Tyrone Unblocked Games Bitlife
Spn 520211
Craigslist Houses For Rent In Milan Tennessee
Engineering Beauties Chapter 1
683 Job Calls
When Does Subway Open And Close
Hannaford Weekly Flyer Manchester Nh
UCLA Study Abroad | International Education Office
WRMJ.COM
Unity Webgl Car Tag
1636 Pokemon Fire Red U Squirrels Download
Big Boobs Indian Photos
Proto Ultima Exoplating
Sam's Club Gas Price Hilliard
WOODSTOCK CELEBRATES 50 YEARS WITH COMPREHENSIVE 38-CD DELUXE BOXED SET | Rhino
Mkvcinemas Movies Free Download
The Menu Showtimes Near Amc Classic Pekin 14
2487872771
Envy Nails Snoqualmie
拿到绿卡后一亩三分地
Aliciabibs
Sephora Planet Hollywood
Merge Dragons Totem Grid
Mta Bus Forums
Sept Month Weather
Noaa Duluth Mn
All Obituaries | Sneath Strilchuk Funeral Services | Funeral Home Roblin Dauphin Ste Rose McCreary MB
Clausen's Car Wash
Best Restaurants West Bend
Stranahan Theater Dress Code
Wgu Admissions Login
A Man Called Otto Showtimes Near Cinemark Greeley Mall
Race Deepwoken
Hughie Francis Foley – Marinermath
Westport gun shops close after confusion over governor's 'essential' business list
Tyrone Unblocked Games Bitlife
Festival Gas Rewards Log In
Lagrone Funeral Chapel & Crematory Obituaries
Latest Posts
Article information

Author: Dr. Pierre Goyette

Last Updated:

Views: 6496

Rating: 5 / 5 (70 voted)

Reviews: 85% of readers found this page helpful

Author information

Name: Dr. Pierre Goyette

Birthday: 1998-01-29

Address: Apt. 611 3357 Yong Plain, West Audra, IL 70053

Phone: +5819954278378

Job: Construction Director

Hobby: Embroidery, Creative writing, Shopping, Driving, Stand-up comedy, Coffee roasting, Scrapbooking

Introduction: My name is Dr. Pierre Goyette, I am a enchanting, powerful, jolly, rich, graceful, colorful, zany person who loves writing and wants to share my knowledge and understanding with you.